State of Alaska Department of Revenue’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

State of Alaska Department of Revenue’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-76,813	Closed	-$291K	–	1655
2020 Q1	$291K	Buy	76,813 +11,554	+18%	+$49.8K	﹤0.01%	1329
2019 Q4	$332K	Sell	65,259 -1,118	-2%	-$5.91K	﹤0.01%	1455
2019 Q3	$335K	Buy	66,377 +37,470	+130%	+$187K	﹤0.01%	1409
2019 Q2	$178K	Buy	28,907 +410	+1%	+$1.98K	﹤0.01%	1483
2019 Q1	$132K	Buy	28,497 +210	+0.7%	+$950	﹤0.01%	1556
2018 Q4	$118K	Buy	28,287 +1,060	+4%	+$5.4K	﹤0.01%	1548
2018 Q3	$170K	Buy	27,227 +3,120	+13%	+$24K	﹤0.01%	1536
2018 Q2	$193K	Buy	24,107 +1,490	+7%	+$11.4K	﹤0.01%	1501
2018 Q1	$168K	Buy	22,617 +8,720	+63%	+$58K	﹤0.01%	1462
2017 Q4	$82K	Hold	13,897	–	–	﹤0.01%	1554
2017 Q3	$102K	Buy	13,897 +170	+1%	+$1.08K	0.01%	1178
2017 Q2	$93K	Buy	13,727 +5,957	+77%	+$44K	0.01%	1120
2017 Q1	$73K	Buy	+7,770	New	+$77.6K	0.01%	1038

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

State of Alaska Department of Revenue's PGNX Position: Q2 2020 in Review

State of Alaska Department of Revenue sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 76,813 shares — an estimated $291K sold.

State of Alaska Department of Revenue first reported a position in PGNX in Q1 2017 and held it in 13 quarters. The position peaked at $335K in Q3 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

State of Alaska Department of Revenue reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
State of Alaska Department of Revenue sold 76,813 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $291K.
State of Alaska Department of Revenue first reported a position in Progenics Pharmaceuticals Inc in Q1 2017 and held it in 13 quarters.
State of Alaska Department of Revenue's Progenics Pharmaceuticals Inc position peaked at $335K in Q3 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2020, filed 6 Jul 2020.